SCHEMBL20548024

SCHEMBL20548024

CC(C)C[C@@H](CC(N)=O)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 3/20 0.57
SLC1A2 P43004 3/20 0.57
MME P08473 3/20 0.50
CPA1 P15085 1/20 0.48
SLC7A5 Q01650 1/20 0.48
LAP3 P28838 2/20 0.47
ANPEP P15144 2/20 0.47
SLC1A1 P43005 2/20 0.44
RNPEP Q9H4A4 2/20 0.43
CACNA2D1 P54289 2/20 0.42
CACNB3 P54284 1/20 0.42
CACNA1C Q13936 1/20 0.42
PGR P06401 1/20 0.42
ADRA1A P35348 1/20 0.42
HTR2B P41595 1/20 0.42
CACNA2D2 Q9NY47 1/20 0.42
DNPEP Q9ULA0 1/20 0.40
GRIK1 P39086 1/20 0.38
GRIK2 Q13002 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094101 1.00 SLC1A3 (0.57) SLC1A3SLC1A2MMECPA1SLC7A5
SCHEMBL28225423 0.85 SLC1A3 (0.57) SLC1A3SLC1A2MMECPA1SLC7A5
SCHEMBL743997 0.84 SLC1A3 (0.43) SLC1A3SLC1A2MMECPA1SLC7A5
SCHEMBL1650677 0.84 SLC1A3 (0.43) SLC1A3SLC1A2MMECPA1SLC7A5
SCHEMBL5870523 0.81 MME (0.56) SLC1A3SLC1A2MMECPA1SLC7A5
SCHEMBL307076 0.81 MME (0.56) SLC1A3SLC1A2MMECPA1SLC7A5
SCHEMBL7262370 0.81 MME (0.56) SLC1A3SLC1A2MMECPA1SLC7A5
SCHEMBL2015332 0.80 SLC1A3 (0.57) SLC1A3SLC1A2SLC7A5SLC1A1ADRA1A
SCHEMBL17387490 0.80 SLC1A3 (0.57) SLC1A3SLC1A2SLC7A5SLC1A1ADRA1A
SCHEMBL276879 0.80 SLC1A3 (0.73) SLC1A3SLC1A2MMECPA1SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615019-A1 MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2020-03-04 EP disclosed
WO-2018200625-A1 MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-11-01 WO disclosed